Showing results (121-130 of 199) with videos related to
Sort By:
Pageof 20
Plos One|July 12, 2013
Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapyZsuzsa Bagoly, Ferenc Sarkady, Tünde Magyar, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleedingE Ajzner, I Balogh, G Haramura, et al.Haematologica|May 10, 2007
Three novel mutations in the glycoprotein IIb gene in a patient with type II Glanzmann thrombastheniaGergely Losonczy, Nurit Rosenberg, Zoltán Boda, et al.Journal of Thrombosis and Haemostasis : JTH|May 17, 2005
Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammationE Katona, B Nagy, J Kappelmayer, et al.Haematologica|February 5, 2008
Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiencyZsuzsanna Bereczky, Helga Bárdos, István Komáromi, et al.Platelets|June 18, 2015
How to test the effect of aspirin and clopidogrel in patients on dual antiplatelet therapy?Zsuzsa Bagoly, Nóra Homoródi, Emese Gyöngyvér Kovács, et al.International Journal of Molecular Sciences|May 28, 2022
The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle CellsRéka Bogáti, Éva Katona, Amir H Shemirani, et al.Journal of Thrombosis and Haemostasis : JTH|November 16, 2021
An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): Communication from the ISTH SSC Subcommittee on Factor XIII and FibrinogenSanj Raut, Éva Katona, Andrew Riches-Duit, et al.Journal of Biomolecular Structure & Dynamics|September 22, 2001
Calcium binding of transglutaminases: a 43Ca NMR study combined with surface polarity analysisA Ambrus, I Bányai, M S Weiss, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2015
Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibodyK Pénzes, C Vezina, Z Bereczky, et al.Pageof 20